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synovial or capsular deposits in the final stage. Marginal boneHistological characteristics of sternoclavicular b2-microglobu-
erosions develop in this late stage.lin amyloidosis and clues for its histogenesis.
Background. The pathogenesis of b2-microglobulin amy-
loidosis (Ab2m) has yet to be fully elucidated.
Methods. We describe the distribution and extent of Ab2m The pathogenesis of b2-microglobulin amyloidosisdeposition and macrophagic infiltration in cartilage, capsule,
(Ab2m), a major complication of dialysis, has yet to beand synovium of sternoclavicular joints obtained postmortem
from 54 patients after 3 to 244 (median 46) months of dialysis. fully understood [1, 2]. In a prospective study of joints
Twenty-four nonuremic patients served as a control group. The obtained at autopsy, we recently reported histological
diagnosis of amyloidosis (A) rested on a positive Congo Red evidence of joint Ab2m in most patients within four yearsstaining (typical birefringence) and that of Ab2m on positive after the onset of hemodiaysis (HD) [3], prior to theimmunostaining of the A deposits with a monoclonal anti-b2m
clinical signs of the disease. We take advantage of theantibody. The size of A deposits was measured.
Results. Ab2m was detected in 32 (59%), and non-b2m amy- availability of whole joints to describe in more detail
loid (Anonb2m) was detected in an additional 8 (15%) of the the distribution of Ab2m and the extent of macrophage
54 dialyzed patients. Ab2m deposits were present in the cartilage infiltration in the various components (cartilage, capsule,of all Ab2m (1) patients (100%). They were localized solely in synovium) of sternoclavicular joints obtained in our au-the cartilage in 27% of the cases, either as a thin patchy layer
topsy study. We identify three stages of Ab2m develop-or as a continuous thicker layer (identified as stage I). Ab2m was
additionally present in the capsule and/or synovium without ment: Ab2m is first observed solely in the cartilage and
macrophages in 27% of the cases (identified as stage II). The subsequently extends to the capsule and synovium. Mac-
correlation between the size of cartilaginous deposits and dial- rophages are not involved in these two stages. In the lastysis duration (P 5 0.02) as well as with the prevalence (P 5
stage, macrophages are recruited only around the larger0.03) and size of capsular deposits (P 5 0.02) suggests that
synovial and capsular deposits, where typical marginalstage II is a later stage of A deposition. Clusters of macrophages
were detected around capsular and synovial amyloid deposits bone erosions develop.
in 46% of the cases (identified as stage III). The longer duration
of dialysis in those with stage III as well as the relationship
between the size of the Ab2m deposits and the prevalence of METHODS
macrophagic infiltration suggests that stage III is the last stage
Dialyzed patientsof Ab2m deposition. Marginal bone erosions were observed in
9 out of 12 patients with stage III deposits. Their size was All dialyzed patients in whom a large (diameter of
correlated with that of cartilaginous deposits (P 5 0.01). more than 2 cm) sternoclavicular joint sample was ob-Among the 24 control patients, Anonb2m was detected in 12
tained at postmortem were included in this study [3, 4].patients (cartilage 100%, capsule 8%, synovium 30%).
Patients who had ever been given a renal transplant wereConclusions. The earliest stage of Ab2m deposition occurs
in the cartilage. Ab2m subsequently extends to capsule and excluded.
synovium. These two first stages do not require macrophage Fifty-four adult dialyzed patients (35 males) were stud-
infiltration. Macrophages are eventually recruited around larger
ied, 34 of whom had been treated exclusively by HD, 16
exclusively by continuous ambulatory peritoneal dialysis
(CAPD), and 4 by both methods. They had been onKey words: dialysis, histogenesis, sternoclavicular joint, macrophage,
cartilage. dialysis for 3 to 244 (median of 46) months. They were
aged 42 to 91 (median of 64) years at the time of dialysis
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The distribution of HD membrane types was similar with a large cytoplasm was observed in the vicinity of
amyloid deposits at a magnification of 3400 (Fig. 2).to that reported in our recent study [3].
b2m amyloid deposits were measured at a magnifica-The etiology of end-stage renal disease was renal vas-
tion of 340 on anti-b2m immunostained slides with ancular disease (N 5 12), chronic pyelonephritis or intersti-
eyepiece squared grid calibrated by a graduated picturetial nephritis (N 5 12), glomerulonephritis (N 5 8), dia-
on the glass surface of the slide. The grid has a surfacebetic nephropathy (N 5 7), polycystic kidney disease
of 1.69 mm2 and is divided in 100. Each scale unit is 130(N 5 6), amyloidosis (N 5 3), hemolytic uremic syn-
mm long and has a surface of 16,900 mm2.drome (N 5 1), and unknown (N 5 5).
The size of b2m amyloid deposits in the cartilage wasThe cause of death was myocardial infarction or heart
measured over five different fields, correspondingfailure (N 5 17), peripheral or cerebrovascular disease
roughly to one third of the cartilage surface. The nonb2m(N 5 7), infection (N 5 15), cancer (N 5 7), cachexia
amyloid deposits were measured with the same tech-(N 5 3), calciphylaxis (N 5 1), chronic obstructive lung
nique on anti-P component immunostained slides. Cap-disease (N 5 1), and unknown (N 5 3).
sular and synovial Ab2m and Anonb2m deposits, unlike
cartilaginous deposits, had highly variable sizes andControl patients
shapes. Therefore, only the largest deposit was measuredTwenty-four adult patients (12 males), aged 14 to 88
per high power field.(median 73) years, without a history of uremia under-
A bone erosion was defined as a loss of bone substance,went postmortem sternoclavicular joint sampling. The
replaced by connective repair tissue. Bone erosions werecause of death was myocardial infarction or heart failure
subdivided into two subgroups according to their loca-(N 5 12), peripheral or cerebrovascular disease (N 5
tion. Those located at the level of reflection of the syno-3), infection (N 5 5), cancer (N 5 2), graft versus host
vial membrane on the cartilage (Fig. 3) were called mar-disease (N 5 1), and autoimmune hepatitis (N 5 1).
ginal erosions, whereas those located at a distance from
the reflection of the synovial membrane on the cartilageJoint specimens
were called subchondral erosions. The surface of boneAll sternoclavicular specimens (one per patient) con-
erosions was estimated as the product of their width bytained both a large cartilaginous and a large capsular
their length.sample and were thus considered representative. Most
Hyperplasia of surface synoviocytes was consideredspecimens [dialyzed patients, 44 (81%); controls, 21
significant when the number of cellular layers was five
(88%)] contained in addition synovium. All specimens
or more, even if hyperplasia was not uniform.
were fixed in 4% buffered formaldehyde, decalcified in
5% formic acid for one to two weeks, embedded in Statistical analysis
paraffin, and cut into serial slides. The slides were stained Results are presented as mean and sd, median and
by hematoxylin eosin and alkaline Congo Red. When range, or percentage of patients at risk, meeting each
detected, amyloid was typed by an avidin-biotin peroxi- criterion. Statistical analysis was performed by the chi-
dase complex and anti-b2m (dilution 1/100; Dako, Co- square test or the Fisher exact test for discrete variables
penhagen, Denmark), anti-P component (dilution 1/500; and by the Mann–Whitney or Kruskal–Wallis test for
Dako), anti-amyloid protein A (dilution 1/500; Dako), continuous variables using the Epidemiology Program
anti-prealbumin (dilution 1/200; Dako) anti-kappa (dilu- Office from the Center for Disease Control (Atlanta,
tion 1/10,000; Bio-yeda, Rehovot, Israel), and anti- GA, USA). Standard Pearson’s linear correlation coef-
lambda (dilution 1/10,000; Bio-yeda, Rehovot, Israel) ficients were also calculated. Differences were consid-
antibodies. ered significant for a P of less than 0.05.
Macrophagic cells were stained by anti-CD68 (dilution
1/50; Dako) [5].
RESULTS
Diagnostic criteria and morphometry Dialyzed patients
The diagnosis of amyloidosis (A) rested on a positive Prevalence of Ab2m and Anonb2m. Among the 54 pa-
Congo Red staining with characteristic green-yellow bi- tients, Ab2m deposits were detected in 32 (59%), and
refringence under polarized light. Anonb2m deposits were detected in 8 (15%; k: N 5 1,
When Congo Red staining was positive, immunoper- unknown N 5 7). No amyloid was found in the 14 re-
oxidase stains were performed with anti-b2m and anti-P maining patients (26%).
component antibodies. Whenever anti-b2m staining was The three groups were comparable for age and gender
negative (Anonb2m), other antibodies were used [6]. distribution, but patients with Ab2m had been on dialysis
The presence of macrophages was considered signifi- for longer than the two other groups (Table 1).
Tissue distribution of amyloid. Whenever amyloid, ei-cant whenever a cluster of five anti-CD68 positive cells
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Table 1. Clinical characteristics of dialyzed and control patients
Dialyzed patients Control patients
Ab2m Anonb2m No amyloid Anonb2m No amyloid
(N 5 32) (N 5 8) (N 5 14) (N 5 12) (N 5 12)
Age at death years 69.5 (56–82) 67 (43–80) NS 66 (53–93) NS 74 (45–88) NS 71.5 (14–88) NS
Age at dialysis onset years 65.5 (46–76) 65.5 (42–78) NS 61.5 (52–91) NS — —
Time on dialysis months 73 (17–244) 16 (3–44) ,0.001 43.5 (6–84) 0.015 — —
Results are presented either as median (range) or as prevalence (%) of patients at risk (N ).
All statistics (P values) are by comparison with the Ab2m group.
Fig. 1. Small cartilaginous Ab2m deposits (arrowheads; A and B) and massive cartilaginous Ab2m deposits (C and D); anti-b2m immunoperoxidase
(left) and anti-CD68 immunoperoxidase (right). There is an absence of macrophagic infiltration (magnification 3250).
ther of b2m or nonb2m type, was detected in the joint, with Ab2m were divided in two groups: those smaller and
those larger than the median value of 0.152 mm2 (Tabledeposits were present in the cartilage. They were ob-
served at least in the superficial layer of either intact or 2). Minor deposits (range of 0.03 to 0.11, median 0.05
mm2) were often patchy, whereas larger deposits (rangefissured cartilage (Fig. 1).
The size of Ab2m deposits ranged from 0.03 to 0.95 of 0.152 to 0.95, median 0.27 mm2) were more frequently
(P 5 0.004) continuous. The duration of dialysis wasmm2 (median 0.152 mm2). To assess the relationship be-
tween the size of cartilage deposits and several other significantly longer in patients with large deposits.
Capsular (range of 0.03 to 0.8, median of 0.09 mm2)pathological characteristics and duration of dialysis, joints
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Table 2. Histological findings in dialyzed patients with small vs. patients in the Ab2m group and 3 out of 19 (16%) inlarge Ab2m cartilaginous deposits
the Anonb2m group (Table 4). They were located under
Small Large P value ulcerated cartilage as a bone erosion (with or without
N 16 16 cavity). They included fibrous tissue, small vessels, some
Duration dialysis months 32.5 96 0.004 macrophages, fragments of altered bone, or cartilage.
(17–160) (24–244)
Ab2m was detected in 7 out of 12 cases of the Ab2mDeposits size mm2 0.051 0.270 0.001
(0.034–0.118) (0.152–0.946) group. Anonb2m was found in one third of the cases of
Continuous deposits in cartilage 31% 88% 0.004 the Anonb2m group.Capsular deposits 38% 81% 0.03
Synovial hyperplasia. Synovial hyperplasia was ob-Capsular macrophages 6% 25% NS
Synovial deposits 38% 77% NS served in 8 out of 26 (31%) patients with Ab2m, in 0 out
Synovial macrophages 23% 69% 0.047 of 7 (0%) patients with Anonb2m, and in 1 out of 11Synovial cells hyperplasia 23% 38% NS
(9%) patients without amyloid (P 5 NS).Marginal bone erosions 23% 46% NS
Subchondral cysts 38% 38% NS Relationship between the localization and size of amy-
loid deposits and time on dialysis. The size of cartilaginousResults are presented either as median (range) or as prevalence (%) of patients
at risk (N). Synovial samples were available only in 13 patients in both subgroups. Ab2m deposits increases with the time spent on dialysis
(N 5 32, r 5 0.59, P 5 0.01) and is correlated with that
of capsular deposits (N 5 19, r 5 0.51, P 5 0.02).
The size of marginal bone erosions is correlated with
the size of Ab2m cartilaginous deposits (r 5 0.78, P 5
0.01 N 5 9) but not with time on dialysis. The sizeand synovial (range of 0.02 to 0.8, median of 0.2 mm2)
deposits were less frequent, both in the Ab2m group (59 of subchondral cysts is not correlated with the size of
cartilaginous Ab2m deposits or with the time of dialysis.and 58%, respectively) and in the Anonb2m group (25
and 14%, respectively; Table 3 and Fig. 2). Capsular In Anonb2m, no correlation was found between the
size of cartilaginous deposits and the size of capsulardeposits were more frequent (P 5 0.03) in the patients
with larger cartilaginous amyloid deposits (Table 2). deposits or time spent on dialysis.
Staging of joint amyloid deposition. Cartilage, capsule,The size of Anonb2m deposits in cartilage ranged from
0.017 to 0.169 (median 0.034) mm2 and was thus much and synovium were simultaneously available in 26 joints
with Ab2m (Fig. 4). Ab2m was localized solely in thesmaller than in Ab2m (P 5 0.006). The few Anonb2m
deposits in capsule (N 5 2) and synovium (N 5 1) were cartilage without macrophages in seven cases (27%). This
stage was identified as stage I. Ab2m was present addi-small (#0.1 mm2).
Distribution and extent of macrophagic infiltra- tionally in the capsule and/or synovium without macro-
phages in seven more cases (27%). This stage was identi-tion. Clusters of macrophages were never detected in
the vicinity of Ab2m or Anonb2m deposits in the carti- fied as stage II. Clusters of macrophages surrounded
synovial and/or capsular deposits in 12 further caseslage. They were more often present around synovial (12
out of 15, 80%) than around capsular (5 out of 19, 26%) (46%). This stage was identified as stage III. Marginal
bone erosions were present in nine of the latter patients.Ab2m deposits (P 5 0.005; Table 3). In the synovium
macrophages were significantly more frequent around The size of cartilaginous Ab2m increased from stage I
(0.03 to 0.19, median of 0.03 mm2) to stage II (0.05 to 0.9,larger than around smaller Ab2m deposits (9 out of 13
vs. 3 out of 13, P 5 0.047; Table 2). Clusters of macro- median of 0.19 mm2) and III (0.03 to 0.95, median of 0.27
mm2; Kruskal–Wallis test for three groups, P 5 0.004).phages were never observed around Anonb2m deposits
in capsule or synovium (Table 3). No significant infiltra- The time on dialysis increased from a mean of 39 [6
17 (sd) months] for stage I to 56 (645 months) for stagetion of other inflammatory cells was observed around
Ab2m and Anonb2m deposits. II and 111 (659 months) for stage III (Kruskal–Wallis
test for three groups, P 5 0.003). The difference betweenBone erosions. Marginal bone erosions (range of 1.4
to 14.9, median of 5.8 mm2) were observed in nine pa- stage II and III does not reach statistical significance
(Mann–Whitney test).tients with Ab2m and in none with Anonb2m (Table 4
and Fig. 3). They were characterized by a cystic dilation
Control patientsof the synovial reflection, including variable amounts of
fibrous tissue with small vessels and macrophages. Ab2m The age distribution was similar in control and dia-
lyzed patients (P 5 0.45).deposits were identified in eight of them. The nine pa-
tients with marginal bone erosions had been on dialysis Twelve of 24 control patients had Anonb2m deposits
[k, N 5 1, amyloid protein A (AA), N 5 2, unknownfor longer (34 to 244, median of 95 months) than patients
with Ab2m but without such marginal erosions (17 to type, N 5 9]. They were older (median of 74 years) than
the control patients without such deposits (median of132, median of 31 months; P 5 0.02).
Subchondral cysts were observed in 12 out of 32 (38%) 71.5 years), but the difference did not reach statistical
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Table 3. Amyloid deposits and macrophages in joints of dialyzed and control patients
Dialyzed patients Control patients
Ab2m Anonb2m No amyloid Anonb2m No amyloid
Cartilage N 5 32 N 5 8 N 5 12
Amyloid 100% 100% — 100% —
Macrophages around amyloid 0% 0% — 0% —
Capsule N 5 32 N 5 8 N 5 12
Amyloid 59% 25% NS — 8% 0.007 —
Macrophages around amyloid 26% 0% NS — 0% NS —
Synovium N 5 26 N 5 7 N 5 10
Amyloid 58% 14% NS — 30% NS —
Macrophages around amyloid 80% 0% ,0.001 — 0% ,0.001 —
Results are presented either as median (range) or as prevalence (%) of patients at risk (N ).
All statistics (P values) are by comparison with the Ab2m group.
Fig. 2. Large capsular Ab2m deposits (arrowheads) without macrophagic infiltration (A and B) and synovial Ab2m deposits (arrowheads) with
macrophages (arrows) in the vicinity (C and D); anti-b2m immunoperoxidase (left) and anti-CD68 immunoperoxidase (right). (Magnifi-
cation 3400.)
significance. Anonb2m deposits were present in the carti- rable to the deposits observed in dialyzed patients with
small Ab2m deposits (Table 3). Clusters of macrophageslage of all positive patients and were less frequently
present in the capsule or the synovium (Table 3). were never observed around Anonb2m deposits.
Marginal bone erosions were never observed, in con-Anonb2m deposits in the cartilage were small (range
of 0.017 to 0.152, median of 0.093 mm2) and thus compa- trast with subchondral erosions (Table 4). Synovial hy-
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Table 4. Bone erosions in joints of dialyzed and control patients
Dialyzed patients Control patients
Ab2m Anonb2m No amyloid Anonb2m No amyloid
N 26 7 11 12 11
Marginal erosion 35% 0% NS 0% 0.035 0% 0.039 0% 0.035
N → N 32 7 12 11 12
Subchondral erosion 38% 43% NS 0% NS 45% NS 16% NS
Results are presented as prevalence (%) of patients at risk (N ).
All statistics (P values) are by comparison with the Ab2m group.
found in dialyzed patients only with Ab2m. By contrast,
the prevalence of subchondral cysts and of synovial hy-
perplasia was similar in both groups (Table 4).
DISCUSSION
In this large study of sternoclavicular joint samples
from dialyzed patients, we demonstrated that the pres-
ence of macrophages is not a prerequisite for Ab2m de-
position. Indeed, Ab2m was deposited in the cartilage
whether as a superficial, patchy layer or as a massive
impregnation without detectable macrophages in their
vicinity. Similarly, significant Ab2m deposits develop in
synovium or capsule in the absence of macrophages.
This finding is in contrast with current views implicat-
ing macrophages in the genesis of Ab2m [5]. In amyloid
protein, light chain derived (AL) and AA amyloidosis,
the precursor protein is proteolyzed by macrophages
prior to its deposition as an amyloid fibril [7, 8]. By
analogy, it has been suggested that macrophages modi-
fied b2m as a first step in the precipitation of Ab2m
fibrils. Indirect evidence was provided by Morita et al,
who detected b2m amyloid filaments within the cyto-
plasm of macrophage-like cells surrounding the amyloid
deposits [9]. Subsequently, Knudsen et al demonstrated
the synthesis and release of b2m by macrophages after
cytokines or lipopolysaccharide stimulation [10], whereas
Campistol et al reported the polymerization of b2m into
Fig. 3. Marginal bone erosion delineated by the arrowheads. Large fibrils in the supernatant of cultures of peripheral blood
Ab2m deposits are present in the cartilage (arrows) and small Ab2m mononuclear cells harvested from dialysis patients [11].deposits within the erosion (Congo Red, magnification 320). C, capsule.
More direct evidence for a central role of macrophages
in b2m fibrillogenesis accrued from the observation that
Ab2m deposits were heavily infiltrated by macrophages
[5]. In the latter studies, however, macrophagic infiltra-perplasia was observed in 0 out of 10 patients with An-
tion was observed in only late (symptomatic) depositsonb2m and 3 out of 11 (27%) without amyloid (NS).
of Ab2m harvested during carpal tunnel syndrome (CTS)In control patients, stage III lesions were thus never
surgery (N 5 6) or from an amyloid bone cyst (N 5 1).identified, although stage I and II lesions were observed.
In contrast, our study includes early preclinical Ab2m
Comparison of dialyzed patients and controls deposits, many of which were confined to the cartilage.
Thus, macrophages are not required for b2m amyloidThe pattern of amyloid deposition was similar in both
fibrils formation. The presence of b2m within the cyto-groups. Whenever detected, amyloid was found in the
cartilage and was less frequently found in capsule and plasm of macrophages is thus best interpreted as a sec-
ondary phenomenon, representing a possibly beneficial,synovium (Table 3).
Macrophages as well as marginal bone erosions were resorptive, catabolic process. Interestingly, Badman et al
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Fig. 4. Schematic representation of the three
stages of Ab2m deposition. Ab2m is represented
in black (bone A, cartilage B, capsule C, syno-
vium D). Macrophages accumulate around sy-
novial Ab2m in stage III.
have recently demonstrated that pancreatic islet amyloid viously reported the absence of macrophages around small
Ab2m deposits in the cartilage in an heterogeneous seriesundergoes internalization by macrophages but resists
proteolytic degradation [12]. of joint samples (vertebral, small and large peripheral
joints) [16]. The size of the deposits was not quantitated,More importantly, we demonstrated that macrophages
are associated with a late stage of b2m amyloid deposi- and macrophages were not detected by specific immuno-
staining. By contrast, Argile´s et al reported large clusterstion. Miyata et al have demonstrated that advanced gly-
cation of b2m attracted macrophages, stimulated the of macrophages around massive Ab2m deposits [5].
There are a few additional words of caution. The de-release of proinflammatory cytokines, and contributed
to bone resorption [13, 14]. This phenomenon might scribed sequence of stages remains hypothetical, as our
study is only cross-sectional and does not provide se-herald the transformation of clinically silent deposits into
symptomatic amyloid masses with pain and bone cysts. quential biopsies in the same patient(s). Furthermore,
only sternoclavicular joints were included. Unlike mostThese data delineate three stages of Ab2m deposition
and might provide a scenario for Ab2m progression in other joints, they contain mainly fibrocartilage rather
than hyaline cartilage and are rarely symptomatic [17,joints. The earliest sign of Ab2m deposition is detected
in the cartilage as a thin, superficial, patchy layer. There- 18]. They were nevertheless chosen because they are a
frequent site of histological Ab2m deposition [3, 4], andafter, the deposit increases in size and becomes continu-
ous. The correlation between the size of the deposits and their small size allows the collection of all joint compo-
nents in the same sample. Whether our findings do applythe duration of dialysis suggests a sequence between these
two pictures, both of which are identified as stage I. to other joints remains to be proven.
Nonb2m (mainly senile?) amyloidosis was detected inSubsequently, Ab2m appears in the capsule and/or in the
synovium (stage II). These latter deposits are observed 8 out of 54 dialyzed patients. This prevalence is certainly
underestimated, as the identification of small nonb2min association with only cartilaginous deposits. The prev-
alence and size of capsular deposits correlate with that deposits is almost impossible in the presence of larger
Ab2m deposits. It reaches 50% in the control group,of cartilaginous deposits. These two findings suggest that
stage II represents a further step in joint Ab2m accumula- in agreement with previous studies [19, 20]. This high
prevalence underscores that diagnostic tests, such as thetion. Macrophage recruitment around capsular and syno-
vial deposits (stage III) appears to be a later phenome- P-component scintigraphy [21], are not specific for Ab2m,
as the P component should be taken up not only bynon, as it is significantly more frequent in joints with
larger Ab2m deposits. It is at this stage that most previous Ab2m but also by Anonb2m deposits. The latter include
not only “senile” amyloidosis, but also, among others,histological observations have been collected [5].
Marginal bone erosions appear only at stage III. Their AL [22] or AA amyloidosis that may coexist with Ab2m
(as observed in one patient in this series).size is significantly correlated with that of cartilaginous
Ab2m. The time on dialysis was significantly longer in The amyloid deposition pattern is similar in Ab2m and
Anonb2m. In both instances, it starts in the superficialpatients with than without marginal erosions. These small
erosions likely represent the early stage of the radiologi- layers of the cartilage and extends only later to other
joint tissues. This similarity suggests that progress incally detectable marginal bone erosions characteristic of
Ab2m [1, 15]. In contrast, the prevalence of subchondral the understanding of the pathogenesis of one type will
contribute to the understanding of the other.bone cysts is not different in dialyzed patients with Ab2m,
Anonb2m, no amyloid, and in controls. Clearly, subchon- Several implications for future studies accrue from the
current observations. First, the presence of Ab2m in adral cysts are not specific for Ab2m.
The various stages identified in this study reconcile sternoclavicular joint sample should not be excluded un-
less cartilage is available. Second, as early Ab2m deposi-various patterns of Ab2m deposition. Athanasou et al pre-
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